These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1301 related articles for article (PubMed ID: 18797453)

  • 1. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
    Karikó K; Muramatsu H; Welsh FA; Ludwig J; Kato H; Akira S; Weissman D
    Mol Ther; 2008 Nov; 16(11):1833-40. PubMed ID: 18797453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.
    Anderson BR; Muramatsu H; Nallagatla SR; Bevilacqua PC; Sansing LH; Weissman D; Karikó K
    Nucleic Acids Res; 2010 Sep; 38(17):5884-92. PubMed ID: 20457754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.
    Kauffman KJ; Mir FF; Jhunjhunwala S; Kaczmarek JC; Hurtado JE; Yang JH; Webber MJ; Kowalski PS; Heartlein MW; DeRosa F; Anderson DG
    Biomaterials; 2016 Dec; 109():78-87. PubMed ID: 27680591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice.
    Andries O; Mc Cafferty S; De Smedt SC; Weiss R; Sanders NN; Kitada T
    J Control Release; 2015 Nov; 217():337-44. PubMed ID: 26342664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.
    Karikó K; Muramatsu H; Ludwig J; Weissman D
    Nucleic Acids Res; 2011 Nov; 39(21):e142. PubMed ID: 21890902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin.
    Karikó K; Muramatsu H; Keller JM; Weissman D
    Mol Ther; 2012 May; 20(5):948-53. PubMed ID: 22334017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N1-methyl-pseudouridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density.
    Svitkin YV; Cheng YM; Chakraborty T; Presnyak V; John M; Sonenberg N
    Nucleic Acids Res; 2017 Jun; 45(10):6023-6036. PubMed ID: 28334758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoenzymatic Preparation of Functional Click-Labeled Messenger RNA.
    Croce S; Serdjukow S; Carell T; Frischmuth T
    Chembiochem; 2020 Jun; 21(11):1641-1646. PubMed ID: 31943671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome-wide mapping of pseudouridines: pseudouridine synthases modify specific mRNAs in S. cerevisiae.
    Lovejoy AF; Riordan DP; Brown PO
    PLoS One; 2014; 9(10):e110799. PubMed ID: 25353621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.
    Pardi N; Tuyishime S; Muramatsu H; Kariko K; Mui BL; Tam YK; Madden TD; Hope MJ; Weissman D
    J Control Release; 2015 Nov; 217():345-51. PubMed ID: 26264835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-dependent relief of translation elongation arrest on pseudouridine- and N1-methyl-pseudouridine-modified mRNAs.
    Svitkin YV; Gingras AC; Sonenberg N
    Nucleic Acids Res; 2022 Jul; 50(13):7202-7215. PubMed ID: 34933339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N
    Chen TH; Potapov V; Dai N; Ong JL; Roy B
    Sci Rep; 2022 Jul; 12(1):13017. PubMed ID: 35906281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation of 2'-modified mRNA in vitro and in vivo.
    Aurup H; Siebert A; Benseler F; Williams D; Eckstein F
    Nucleic Acids Res; 1994 Nov; 22(23):4963-8. PubMed ID: 7800487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of a U1/mRNA 5' splice site duplex containing pseudouridine as measured by thermodynamic and NMR methods.
    Hall KB; McLaughlin LW
    Biochemistry; 1991 Feb; 30(7):1795-801. PubMed ID: 1993194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epitranscriptome in Translation Regulation.
    Peer E; Moshitch-Moshkovitz S; Rechavi G; Dominissini D
    Cold Spring Harb Perspect Biol; 2019 Aug; 11(8):. PubMed ID: 30037968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximizing the Translational Yield of mRNA Therapeutics by Minimizing 5'-UTRs.
    Trepotec Z; Aneja MK; Geiger J; Hasenpusch G; Plank C; Rudolph C
    Tissue Eng Part A; 2019 Jan; 25(1-2):69-79. PubMed ID: 29638193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside Modified mRNA Vaccines for Infectious Diseases.
    Pardi N; Weissman D
    Methods Mol Biol; 2017; 1499():109-121. PubMed ID: 27987145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments, opportunities, and challenges in the study of mRNA pseudouridylation.
    Gilbert WV
    RNA; 2024 Apr; 30(5):530-536. PubMed ID: 38531650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mRNA Modifications on Translation: An Overview.
    Roy B
    Methods Mol Biol; 2021; 2298():327-356. PubMed ID: 34085254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA pseudouridylation affects RNA metabolism in the parasite
    Nakamoto MA; Lovejoy AF; Cygan AM; Boothroyd JC
    RNA; 2017 Dec; 23(12):1834-1849. PubMed ID: 28851751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.